Use of Sacral Neuromodulation in the Management of ... - SUNA

More documents

Recommendations

Info

InterStim Therapy Cumulative Use World-wide 100000 80000 60000 40000 20000 Technique Change – 2002 Percutaneous Tined Lead Placement 0 1998 2000 2002 2004 2006 2008 2010 More than 85,000 patients have received InterStim Therapy
Program Goal To discuss the prevalence & treatment of urinary control problems and the use of sacral neuromodulation as a treatment option for patients with urinary urgency-frequency, urinary urge incontinence and/or urinary retention who fail or cannot tolerate conservative treatments.
Page 1: Use of Sacral Neuromodulation in th
Page 5 and 6: Voiding Dysfunction: A Hidden Probl
Page 7 and 8: Filling Phase • Automatic Actions
Page 9 and 10: Abnormal Micturition Voiding dysfun
Page 11 and 12: Overview Sacral Nerve Stimulation (
Page 13 and 14: SNS - Therapy SNS utilizes mild ele
Page 15 and 16: Pharmacotherapy vs. SNS Therapy Pha
Page 17 and 18: 5-Year Clinical Efficacy Urge Incon
Page 19 and 20: 5-Year Clinical Efficacy Urinary Re
Page 21 and 22: Treatment Algorithm For Urinary Urg
Page 23 and 24: Other Issues Influencing Patient Se
Page 25 and 26: Test & Implant Procedures • 1 st
Page 27 and 28: Voiding Diary Documentation 3 days
Page 29 and 30: 2 nd Stage Implant Procedure 2 nd S
Page 31 and 32: Benefits of SNS Potential Adverse E
Page 33 and 34: Case Studies Retention with frequen
Page 35 and 36: Voiding Diary • Pt voids 2-4 oz q
Page 37 and 38: Strains to Void
Page 39 and 40: Urodynamic Results • Normal stora
Page 41 and 42: Post InterStim Implant • Doing ex
Page 43 and 44: Utilization of Multiple Modalities
Page 45 and 46: Management of Care • Life choices
Page 47 and 48: Summary • SNS is an effective tre
Page 49 and 50: Revision for SUNA Oct 2010 - Lisa Z

Use of Sacral Neuromodulation in the Management of ... - SUNA

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?